Sponsored by:
Leading the Way in Biotech Solutions Across JAPAC
Are you a U.S. biotech company struggling with patient recruitment, prolonged study timelines, rising costs, or unlocking the full value of your asset in key markets such as Japan or China
Are you a U.S. biotech company struggling with patient recruitment, prolonged study timelines, rising costs, or unlocking the full value of your asset in key markets such as Japan or China?
Running your studies in the Japan Asia-Pacific (JAPAC) region could be the solution. Discover IQVIA Biotech’s differentiated capabilities in JAPAC and how we can accelerate your clinical development journey.
Unmatched expertise in patient recruitment and retention
Patient recruitment and retention remain among the most significant challenges in clinical trials. IQVIA Biotech’s comprehensive recruitment approach blends proven methodologies with innovative solutions to keep studies on track.
Our specialty recruitment function delivers a 360 approach, deploying Clinical Trial Educators (CTEs) to collaborate with site teams and referral networks, while leveraging Direct‑to‑Patient (DTP) recruitment and advanced digital technologies.
